<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Vrijhoef, H.J.M.</title>
    <link>http://repub.eur.nl/res/aut/19492/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>The effectiveness of chronic care management for heart failure: Meta-regression analyses to explain the heterogeneity in outcomes (Article)</title>
      <link>http://repub.eur.nl/res/pub/37408/</link>
      <pubDate>2012-10-01T00:00:00Z</pubDate>
      <description>Objective To support decision making on how to best redesign chronic care by studying the heterogeneity in effectiveness across chronic care management evaluations for heart failure. Data Sources Reviews and primary studies that evaluated chronic care management interventions. Study Design A systematic review including meta-regression analyses to investigate three potential sources of heterogeneity in effectiveness: study quality, length of follow-up, and number of chronic care model components. Principal Findings Our meta-analysis showed that chronic care management reduces mortality by a mean of 18 percent (95 percent CI: 0.72-0.94) and hospitalization by a mean of 18 percent (95 percent CI: 0.76-0.93) and improves quality of life by 7.14 points (95 percent CI: -9.55 to -4.72) on the Minnesota Living with Heart Failure questionnaire. We could not explain the considerable differences in hospitalization and quality of life across the studies. Conclusion Chronic care management significantly reduces mortality. Positive effects on hospitalization and quality of life were shown, however, with substantial heterogeneity in effectiveness. This heterogeneity is not explained by study quality, length of follow-up, or the number of chronic care model components. More attention to the development and implementation of chronic care management is needed to support informed decision making on how to best redesign chronic care. </description>
    </item> <item>
      <title>Early results from Adoption of bundled payment for diabetes care in the Netherlands show improvement in care coordination (Article)</title>
      <link>http://repub.eur.nl/res/pub/38367/</link>
      <pubDate>2012-02-01T00:00:00Z</pubDate>
      <description>In 2010 a bundled payment system for diabetes care, chronic
obstructive pulmonary disease care, and vascular risk management was
introduced in the Netherlands. Health insurers now pay a single fee to a
contracting entity, the care group, to cover all of the primary care needed
by patients with these chronic conditions. The initial evaluation of the
program indicated that it improved the organization and coordination of
care and led to better collaboration among health care providers and
better adherence to care protocols. Negative consequences included
dominance of the care group by general practitioners, large price
variations among care groups that were only partially explained by
differences in the amount of care provided, and an administrative burden
caused by outdated information and communication technology systems.
It is too early to draw conclusions about the effects of the new payment
system on the quality or the overall costs of care. However, the
introduction of bundled payments might turn out to be a useful step in
the direction of risk-adjusted integrated capitation payments for
multidisciplinary provider groups offering primary and specialty care to a
defined group of patients.</description>
    </item> <item>
      <title>Chronic care management for patients with COPD: A critical review of available evidence (Article)</title>
      <link>http://repub.eur.nl/res/pub/32943/</link>
      <pubDate>2011-12-05T00:00:00Z</pubDate>
      <description>Rationale, aims and objectives Clinical diversity and methodological heterogeneity exists between studies on chronic care management. This study aimed to examine the effectiveness of chronic care management in chronic obstructive pulmonary disease (COPD) while taking heterogeneity into account, enabling the understanding of and the decision making about such programmes. Three investigated sources of heterogeneity were study quality, length of follow-up, and number of intervention components. Methods We performed a review of previously published reviews and meta-analyses on COPD chronic care management. Their primary studies that were analyzed as statistical, clinical and methodological heterogeneity were present. Meta-regression analyses were performed to explain the variances among the primary studies. Results Generally, the included reviews showed positive results on quality of life and hospitalizations. Inconclusive effects were found on emergency department visits and no effects on mortality. Pooled effects on hospitalizations, emergency department visits and quality of life of primary studies did not reach significant improvement. No effects were found on mortality. Meta-regression showed that the number of components of chronic care management programmes explained present heterogeneity for hospitalizations and emergency department visits. Four components showed significant effects on hospitalizations, whereas two components had significant effects on emergency department visits. Methodological study quality and length of follow-up did not significantly explain heterogeneity. Conclusions This study demonstrated that COPD chronic care management has the potential to improve outcomes of care; heterogeneity in outcomes was explained. Further research is needed to elucidate the diversity between COPD chronic care management studies in terms of the effects measured and strengthen the support for chronic care management. </description>
    </item> <item>
      <title>Identifying potentially cost effective chronic care programs for people with COPD (Article)</title>
      <link>http://repub.eur.nl/res/pub/16278/</link>
      <pubDate>2009-01-01T00:00:00Z</pubDate>
      <description>Objective: To review published evidence regarding the cost effectiveness of multi-component COPD programs and to illustrate how potentially cost effective programs can be identified. Methods: Systematic search of Medline and Cochrane databases for evaluations of multicomponent disease management or chronic care programs for adults with COPD, describing process, intermediate, and end results of care. Data were independently extracted by two reviewers and descriptively summarized. Results: Twenty articles describing 17 unique COPD programs were included. There is little evidence for significant improvements in process and intermediate outcomes, except for increased provision of patient self-management education and improved disease-specific knowledge. Overall, the COPD programs generate end results equivalent to usual care, but programs containing ≥3 components show lower relative risks for hospitalization. There is limited scope for programs to break-even or save money. Conclusion: Identifying cost effective multi-component COPD programs remains a challenge due to scarce methodologically sound studies that demonstrate significant improvements on process, intermediate and end results of care. Estimations of potential cost effectiveness of specific programs illustrated in this paper can, in the absence of 'perfect data', support timely decision-making regarding these programs. Nevertheless, well-designed health economic studies are needed to decrease the current decision uncertainty.</description>
    </item>
  </channel>
</rss>